Showing results (701-710 of 1,838) with videos related to

Sort By:
Pageof 184
ESMO Open|July 13, 2019
Immune checkpoint inhibitor treatment in patients with oncogene- addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussionAnna S Berghoff, Beatriz Bellosillo, Christophe Caux, et al.
ESMO Open|March 1, 2021
How to use liquid biopsies to treat patients with cancerL De Mattos-Arruda, G Siravegna
ESMO Open|March 18, 2021
Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysisS Peleg Hasson, M R Brezis, E Shachar, et al.
ESMO Open|March 18, 2021
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancerG L Banna, A Cortellini, D L Cortinovis, et al.
ESMO Open|March 20, 2021
CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysisE Agostinetto, L Vian, R Caparica, et al.
ESMO Open|November 11, 2021
Distribution of the workforce involved in cancer care: a systematic review of the literatureD Trapani, S S Murthy, M Boniol, et al.
ESMO Open|November 9, 2021
Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020M Maliepaard, W Carree, M T J van Bussel
ESMO Open|April 15, 2022
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort studyA Lasagna, F Bergami, D Lilleri, et al.
ESMO Open|March 11, 2022
Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trialsV Guarneri, G Griguolo, F Miglietta, et al.
ESMO Open|May 17, 2018
Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignanciesMidori Tanaka, Hidehito Horinouchi, Yasushi Goto, et al.
Pageof 184